Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-03

Clinical Trial Update: Safety and Efficacy of Lansoprazole in Patients With Reflux Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the safety and efficacy of Lansoprazole for gastroesophageal reflux disease; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole (Lansoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux | Phase 4 | Status: COMPLETED | Results posted: 2012-09-03